GAMCO Investors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.9M Sell
231,107
-867
-0.4% -$79.6K 0.21% 138
2025
Q4
$20.9M Sell
231,974
-7,869
-3% -$746K 0.2% 138
2025
Q3
$23.6M Sell
239,843
-6,112
-2% -$606K 0.23% 117
2025
Q2
$22.4M Buy
245,955
+45,164
+22% +$4.37M 0.22% 117
2025
Q1
$22.7M Sell
200,791
-7,610
-4% -$814K 0.25% 108
2024
Q4
$22M Sell
208,401
-4,931
-2% -$529K 0.23% 118
2024
Q3
$23M Sell
213,332
-1,856
-0.9% -$203K 0.24% 119
2024
Q2
$23.4M Sell
215,188
-11,815
-5% -$1.39M 0.25% 109
2024
Q1
$30M Sell
227,003
-2,432
-1% -$304K 0.3% 85
2023
Q4
$27.9M Sell
229,435
-7,351
-3% -$820K 0.3% 87
2023
Q3
$26.6M Sell
236,786
-18,398
-7% -$2.34M 0.31% 89
2023
Q2
$37.2M Sell
255,184
-16,149
-6% -$2.19M 0.39% 68
2023
Q1
$35.1M Sell
271,333
-37,981
-12% -$4.77M 0.38% 72
2022
Q4
$39.4M Sell
309,314
-5,564
-2% -$646K 0.42% 59
2022
Q3
$32.9M Sell
314,878
-1,490
-0.5% -$164K 0.39% 67
2022
Q2
$33.2M Buy
316,368
+12,655
+4% +$1.5M 0.36% 79
2022
Q1
$38.8M Buy
303,713
+23,754
+8% +$2.86M 0.35% 76
2021
Q4
$34.5M Sell
279,959
-1,571
-0.6% -$206K 0.3% 94
2021
Q3
$40M Buy
281,530
+11,573
+4% +$1.7M 0.35% 77
2021
Q2
$42.1M Buy
269,957
+1,321
+0.5% +$214K 0.36% 78
2021
Q1
$41.8M Sell
268,636
-3,786
-1% -$586K 0.37% 78
2020
Q4
$40.8M Sell
272,422
-7,805
-3% -$1.1M 0.38% 71
2020
Q3
$37M Sell
280,227
-19,014
-6% -$2.48M 0.41% 68
2020
Q2
$34.7M Sell
299,241
-50,078
-14% -$5.77M 0.39% 74
2020
Q1
$34.3M Sell
349,319
-15,645
-4% -$2.05M 0.41% 69
2019
Q4
$53M Sell
364,964
-15,805
-4% -$2.18M 0.42% 65
2019
Q3
$50.7M Sell
380,769
-35,340
-8% -$4.57M 0.42% 69
2019
Q2
$47.6M Sell
416,109
-16,827
-4% -$1.97M 0.36% 80
2019
Q1
$53.7M Sell
432,936
-26,602
-6% -$3.02M 0.41% 72
2018
Q4
$46.3M Sell
459,538
-39,794
-8% -$4.48M 0.39% 74
2018
Q3
$63.7M Sell
499,332
-54,724
-10% -$6.51M 0.43% 71
2018
Q2
$59.9M Sell
554,056
-26,830
-5% -$2.92M 0.41% 76
2018
Q1
$61.5M Buy
580,886
+48,588
+9% +$5.64M 0.41% 75
2017
Q4
$62.4M Buy
532,298
+31,801
+6% +$3.6M 0.39% 78
2017
Q3
$56.9M Buy
500,497
+178,269
+55% +$20.6M 0.35% 86
2017
Q2
$40.2M Buy
322,228
+38,729
+14% +$4.59M 0.26% 113
2017
Q1
$33.6M Buy
283,499
+52,798
+23% +$5.98M 0.21% 127
2016
Q4
$23.1M Sell
230,701
-4,214
-2% -$452K 0.15% 167
2016
Q3
$29.7M Sell
234,915
-14,656
-6% -$1.81M 0.19% 140
2016
Q2
$29.2M Sell
249,571
-4,429
-2% -$501K 0.19% 135
2016
Q1
$26.3M Sell
254,000
-20,806
-8% -$2.01M 0.17% 154
2015
Q4
$27.4M Sell
274,806
-2,678
-1% -$262K 0.18% 150
2015
Q3
$25.3M Sell
277,484
-19,483
-7% -$1.95M 0.17% 152
2015
Q2
$31.5M Sell
296,967
-14,986
-5% -$1.66M 0.17% 154
2015
Q1
$35.6M Sell
311,953
-1,854
-0.6% -$212K 0.19% 150
2014
Q4
$34.6M Sell
313,807
-9,084
-3% -$958K 0.18% 154
2014
Q3
$31.5M Buy
322,891
+5,526
+2% +$544K 0.17% 160
2014
Q2
$32M Sell
317,365
-289
-0.1% -$28.2K 0.17% 159
2014
Q1
$29.2M Sell
317,654
-7,313
-2% -$674K 0.16% 165
2013
Q4
$29.4M Sell
324,967
-1,906
-0.6% -$165K 0.16% 167
2013
Q3
$26.1M Sell
326,873
-12,154
-4% -$957K 0.15% 170
2013
Q2
$24.7M Buy
+339,027
New +$25.3M 0.16% 169

Other funds holding ZBH

GAMCO Investors's ZBH Position: Q1 2026 in Review

GAMCO Investors reduced its Zimmer Biomet (ZBH) stake by 0.37% in Q1 2026, selling an estimated $79.6K and leaving 231,107 shares worth $20.9M. The position accounts for 0.21% of the portfolio, ranked #138.

GAMCO Investors first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $63.7M in Q3 2018. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • GAMCO Investors held 231,107 shares of Zimmer Biomet worth $20.9M as of Q1 2026.
  • GAMCO Investors sold 867 Zimmer Biomet shares in Q1 2026, an estimated $79.6K.
  • Zimmer Biomet made up 0.21% of GAMCO Investors's portfolio in Q1 2026, its #138 holding.
  • GAMCO Investors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • GAMCO Investors's Zimmer Biomet position peaked at $63.7M in Q3 2018.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on GAMCO Investors's 13F filing for Q1 2026, filed 14 May 2026.